-+ 0.00%
-+ 0.00%
-+ 0.00%

GSK CANADA AND THE PAN-CANADIAN PHARMACEUTICAL ALLIANCE SIGN LETTER OF INTENT FOR BLENREP FOR THE TREATMENT OF RELAPSED OR REFRACTORY MULTIPLE MYELOMA

Reuters·09/22/2026 11:00:22

Please log in to view news